TNX-102 SL Tablet 2.8 mg

Drug identity checked against registry records

Also recorded as cyclobenzaprine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia PatientsNCT02589275Tonix Pharmaceuticals, Inc.Phase 3Completed2016-09-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.